Detalles de la búsqueda
1.
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
Br J Cancer
; 130(5): 769-776, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184691
2.
A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.
BMC Cancer
; 22(1): 575, 2022 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35606739
3.
Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients.
Cancer Invest
; 33(4): 114-20, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25674700
4.
Intensity modulated arc therapy in bilaterally irradiated head and neck cancer: a comparative and prospective multicenter planning study.
Cancer Invest
; 32(5): 159-67, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24605900
5.
Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.
Strahlenther Onkol
; 190(6): 546-54, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24615188
6.
A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.
Anticancer Drugs
; 25(8): 970-5, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24849707
7.
Nomograms to predict late urinary toxicity after prostate cancer radiotherapy.
World J Urol
; 32(3): 743-51, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23990073
8.
Ultra-hypofractionated prostate cancer radiotherapy: Dosimetric impact of real-time intrafraction prostate motion and daily anatomical changes.
Phys Med
; 118: 103207, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38215607
9.
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07).
Eur Urol
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490854
10.
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial.
Eur Urol Oncol
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734543
11.
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Clin Transl Radiat Oncol
; 44: 100702, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38111609
12.
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials.
J Clin Oncol
; 42(18): 2132-2138, 2024 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38471051
13.
Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial.
Radiother Oncol
; 193: 110116, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316193
14.
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines.
Radiother Oncol
; 195: 110273, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38588921
15.
Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients.
Anticancer Drugs
; 24(6): 623-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23542750
16.
A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial.
Eur Urol Open Sci
; 54: 80-87, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545850
17.
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group.
Radiother Oncol
; 180: 109460, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638842
18.
Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 9(8): 1056-1064, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37261806
19.
Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02).
Eur J Cancer
; 178: 114-127, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36434888
20.
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study.
Eur Urol Oncol
; 6(4): 399-405, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754722